OTCPicks.com Stocks to Watch for Wednesday, November 12th OPTR, RPTP, NMKT, LNET, GNVC

Our Stocks to Watch tomorrow include Optimer Pharmaceuticals Inc. (Nasdaq: OPTR), Raptor Pharmaceuticals Corp. (OTCBB: RPTP), NewMarket Technology Inc. (OTC: NMKT), LodgeNet Interactive Corp. (Nasdaq: LNET) and GenVec Inc. (Nasdaq: GNVC).

OPTIMER PHARMACEUTICALS INCORPORATED (NASDAQ: OPTR)

"Up 99.57% on Tuesday"

Optimer Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing innovative anti-infective products to treat serious infections and address unmet medical needs. Optimer has two late-stage anti-infective product candidates under development. OPT-80 is the only antibiotic therapy currently in Phase 3 worldwide clinical development for Clostridium difficile infection. Prulifloxacin is an antibiotic being developed for the treatment of travelers’ diarrhea, a form of infectious diarrhea.

RAPTOR PHARMACEUTICALS INCORPORATED (OTCBB: RPTP)

"Up 38.89% on Tuesday"

Raptor Pharmaceuticals Corp. ("Raptor") is dedicated to speeding the delivery of new treatment options to patients by working to improve existing therapeutics through the application of highly specialized drug targeting platforms and formulation expertise. We focus on underserved patient populations where we can have the greatest potential impact. Raptor is currently running clinical trials in patients with aldehyde dehydrogenase ("ALDH2") deficiency, nephropathic cystinosis and non-alcoholic steatohepatitis ("NASH"). Raptor's preclinical programs are based upon bioengineered novel drug candidates and drug-targeting platforms derived from the human receptor-associated protein ("RAP") and related proteins to that are designed to target cancer, neurodegenerative disorders and infectious diseases.

NEWMARKET TECHNOLOGY INCORPORATED (OTCBB: NMKT)

"Up 29.55% on Tuesday"

NewMarket Technology, Inc. provides voice over Internet protocol telephony, systems integration, homeland security, and wireless broadband technology solutions in the United States and internationally. It provides voice over Internet protocol services, broadband wireless services, proprietary healthcare practice management software, proprietary defense industry system solutions, voice mail and messaging services, prepaid long-distance calling card services, e-commerce communications services for businesses selling products and services over the Internet, contact management solutions, and electronic data interchange software, as well as corporate long-distance, fax, and data networking services. The company also provides technical independent consulting, and security services. It serves national and international corporations; service providers, including Internet service providers, application service providers, local exchange carriers, and competitive local exchange carriers; and governments and government agencies. The company was formerly known as IPVoice Communications, Inc. and changed its name to NewMarket Technology, Inc. in 2004. NewMarket Technology is headquartered in Dallas, Texas.

LODGENET INTERACTIVE CORPORATION (NASDAQ: LNET)

"Up 16.67% on Tuesday"

LodgeNet Interactive Corporation is the leading provider of media and connectivity solutions designed to meet the unique needs of hospitality, healthcare and other guest-based businesses. LodgeNet Interactive serves more than 1.9 million hotel rooms representing 10,000 hotel properties worldwide in addition to healthcare facilities throughout the United States. The company's services include: Interactive Television Solutions, Broadband Internet Solutions, Content Solutions, Professional Solutions and Advertising Media Solutions. LodgeNet Interactive Corporation owns and operates businesses under the industry leading brands: LodgeNet, LodgeNetRX, and The Hotel Networks.

GENVEC INCORPORATED (NASDAQ: GNVC)

"Up 16.33% on Tuesday"

GenVec, Inc. is a biopharmaceutical company developing novel therapeutic drugs and vaccines. GenVec’s lead product candidate, TNFerade™, is currently in a pivotal clinical study (PACT) in locally advanced pancreatic cancer and is being evaluated in additional clinical trials in other tumor types. GenVec also uses its proprietary adenovector technology to develop vaccines for infectious diseases including foot-and-mouth disease, malaria, HIV, respiratory syncytial virus (RSV), HSV-2, and influenza.

About OTCPicks.com

Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.

Disclosure: OTCPicks.com has not been compensated by any of the companies covered in this release.

OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.